Skip to main content

Table 1 Clinical characteristics and MRI features of patients

From: Better efficacy in differentiating WHO grade II from III oligodendrogliomas with machine-learning than radiologist’s reading from conventional T1 contrast-enhanced and fluid attenuated inversion recovery images

Variable

ODG2

ODG3

Total

P value

No. of patients, n

19

17

36

NA

Location, n (%)

0.378

 Frontal

10/19 (52.6)

10/17 (58.8)

20/36 (55.6)

 

 Temporal

3/19 (15.8)

5/17 (29.4)

8/36 (22.2)

 

 Parietal

3/19 (15.8)

1/17 (5.9)

4/36 (11.1)

 

 Insular

1/19 (5.3)

1/17 (5.9)

2/36 (5.6)

 

 Occipital

0/19 (0)

0/17 (0)

0/36 (0)

 

 Others

2/19 (10.5)

0/17 (0)

2/36 (5.6)

 

Gender, n (%)

0.202

 Male

8/19 (42.1)

11/17 (64.7)

19/36 (52.8)

 

 Female

11/19 (57.9)

6/17 (35.3)

17/36 (47.2)

 

Age a

0.788

 Mean ± SD

45.6 ± 13.7

44.3 ± 15.1

45.0 ± 14.4

 

Signal, n (%)

0.092

 Homogeneous

6/19 (31.6)

1/17 (5.9)

7/36 (19.4)

 

 Heterogeneous

13/19 (68.4)

16/17 (94.1)

29/36 (80.6)

 

Tumor cross midline, n (%)

1.000

 No

16/19 (84.2)

14/17 (82.4)

30/36 (83.3)

 

 Yes

3/19 (15.8)

3/17 (17.6)

6/36 (16.7)

 

Multiple foci, n (%)

0.736

 No

12/19 (63.2)

9/17 (52.9)

21/36 (58.3)

 

 Yes

7/19 (36.8)

8/17 (47.1)

15/36 (41.7)

 

Necrosis, n (%)

0.044*

 No

13/19 (68.4)

5/17 (29.4)

18/36 (50.0)

 

 Yes

6/19 (31.6)

12/17 (70.6)

18/36 (50.0)

 

Cyst, n (%)

0.255

 No

16/19 (84.2)

11/17 (64.7)

27/36 (75.0)

 

 Yes

3/19 (15.8)

6/17 (35.3)

9/36 (25.0)

 

Edema, n (%)

0.106

 No

4/19 (21.1)

0/17 (0)

4/36 (11.1)

 

 Yes

15/19 (78.9)

17/17 (100.0)

32/36 (88.9)

 

Border, n (%)

1.000

 Sharp/smooth

2/19 (10.5)

1/17 (5.9)

3/36 (8.3)

 

 Indistinct/irregular

17/19 (89.5)

16/17 (94.1)

33/36 (91.7)

 

Enhancement, n (%)

0.002*

 No/blurry

15/19 (78.9)

4/17 (23.5)

19/36 (52.8)

 

 Nodular/ring-like

4/19 (21.1)

13/17 (76.5)

17/36 (47.2)

 

Cognitive dysfunction, n (%)

0.274

 No

7/19 (36.8)

3/17 (17.6)

10/36 (27.8)

 

 Yes

12/19 (63.2)

14/17 (82.4)

26/36 (72.2)

 

Epileptic seizures, n (%)

1.000

 No

10/19 (52.6)

9/17 (52.9)

19/36 (52.8)

 

 Yes

9/19 (47.4)

8/17 (47.1)

17/36 (47.2)